Zhejiang Jiahua Energy Chemical Industry Co.,Ltd. (600273.SS)
Jiaxing, SH, CN
Zhejiang Jiahua Energy Chemical Industry Co.,Ltd. manufactures and sells chemicals in China. The company offers chlor-alkali products, including industrial Hydrochloric acid, industrial liquid chlorine, sodium hypochlorite, industrial sodium hydroxide, and hydrogen; sulfuric acid, which includes sulfuric acid, fuming sulfuric acid, liquid SO3, AR acid, and chlorosulfonic acid; and hot supply products, such as steam and demineralized water products. It also provides ortho/para products comprises ise p-toluenesulfonyl chloride, p-methylsulfonyltoluenetoluene, p-toluenesulfonyl isocyanate, o/p-toluenesulfonyl chloride, dry product 2-nitro-4- methylsulfonyltoluene, and wet product 2-nitro-4- methylsulfonyltoluene; and fatty acids and alcohols, and glycerin. The company was formerly known as Huafang Textile Co., Ltd. and changed its name to Zhejiang Jiahua Energy Chemical Industry Co.,Ltd. in December 2014. Zhejiang Jiahua Energy Chemical Industry Co.,Ltd. was founded in 1998 and is headquartered in Jiaxing, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.14% | -4.33% | -10.65% | -36.85% | -12.26% | -16.48% | -10.10% | -22.59% | -16.28% | -6.05% | +38.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+11.2% ★ Q1'26: +11.7% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+0.0% Q1'26: -61.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+5.2% ★ Q1'26: +4.3% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+11.3% ★ Q1'26: +7.8% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+9.8% ★ Q1'26: +6.8% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-2.0% ★ Q1'26: -3.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.67× ★ Q1'26: 2.09× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.50B
est: 3.94B (+14.4%)
|
5.58B
est: 4.89B (+14.1%)
|
5.60B
est: 6.13B (-8.6%)
|
5.37B
est: 5.79B (-7.2%)
|
5.57B
est: 5.48B (+1.6%)
|
9.06B
est: 7.23B (+25.3%)
|
11.50B
est: 9.42B (+22.2%)
|
8.77B
est: 11.08B (-20.8%)
|
9.15B
est: 12.12B (-24.5%)
|
10.18B
est: 10.86B (-6.2%)
|
11.56B
11.56B – 11.56B
+6.4% YoY
|
12.58B
12.58B – 12.58B
+8.8% YoY
|
13.18B
13.18B – 13.18B
+4.8% YoY
|
| EBITDA |
1.29B
est: 1.02B (+26.6%)
|
1.57B
est: 1.27B (+23.9%)
|
1.71B
est: 1.59B (+7.5%)
|
1.92B
est: 1.50B (+28.1%)
|
2.01B
est: 1.42B (+41.0%)
|
2.64B
est: 1.88B (+40.4%)
|
2.58B
est: 2.44B (+5.5%)
|
1.96B
est: 2.88B (-31.8%)
|
1.82B
est: 2.72B (-33.1%)
|
1.90B
est: 2.44B (-22.2%)
|
2.60B
2.60B – 2.60B
+6.4% YoY
|
2.83B
2.83B – 2.83B
+8.8% YoY
|
2.96B
2.96B – 2.96B
+4.8% YoY
|
| EBIT |
960.91M
est: 729.12M (+31.8%)
|
1.17B
est: 905.24M (+29.8%)
|
1.28B
est: 1.14B (+12.9%)
|
1.45B
est: 1.07B (+34.9%)
|
1.50B
est: 1.02B (+48.2%)
|
2.06B
est: 1.34B (+53.9%)
|
1.90B
est: 1.74B (+9.0%)
|
1.26B
est: 2.05B (-38.7%)
|
1.10B
est: 1.86B (-41.2%)
|
1.15B
est: 1.67B (-30.9%)
|
1.78B
1.78B – 1.78B
+6.4% YoY
|
1.93B
1.93B – 1.93B
+8.8% YoY
|
2.03B
2.03B – 2.03B
+4.8% YoY
|
| Net Income |
740.48M
est: 835.26M (-11.3%)
|
968.53M
est: 898.82M (+7.8%)
|
1.10B
est: 1.17B (-6.1%)
|
1.23B
est: 1.23B (+0.1%)
|
1.30B
est: 1.17B (+11.3%)
|
1.81B
est: 1.43B (+26.6%)
|
1.60B
est: 1.84B (-13.0%)
|
1.18B
est: 1.74B (-32.3%)
|
1.01B
est: 1.80B (-44.1%)
|
987.75M
est: 1.13B (-12.9%)
|
987.75M
987.75M – 987.75M
-12.9% YoY
|
1.13B
1.13B – 1.13B
+14.9% YoY
|
1.29B
1.29B – 1.29B
+14.1% YoY
|
| SGA |
255.48M
est: 81.32M (+214.1%)
|
180.12M
est: 100.97M (+78.4%)
|
191.50M
est: 126.60M (+51.3%)
|
177.99M
est: 119.50M (+48.9%)
|
148.87M
est: 113.22M (+31.5%)
|
175.04M
est: 149.39M (+17.2%)
|
186.36M
est: 194.50M (-4.2%)
|
190.46M
est: 228.87M (-16.8%)
|
176.89M
est: 197.62M (-10.5%)
|
50.91M
est: 177.07M (-71.2%)
|
188.48M
188.48M – 188.48M
+6.4% YoY
|
205.14M
205.14M – 205.14M
+8.8% YoY
|
214.89M
214.89M – 214.89M
+4.8% YoY
|
| EPS |
0.57
est: 0.61 (-7.1%)
|
0.70
est: 0.66 (+6.1%)
|
0.75
est: 0.86 (-12.8%)
|
0.88
est: 0.90 (-2.2%)
|
0.94
est: 0.86 (+9.3%)
|
1.29
est: 1.05 (+22.9%)
|
1.15
est: 1.35 (-14.8%)
|
0.85
est: 1.28 (-33.6%)
|
0.74
est: 1.35 (-45.2%)
|
0.74
est: 0.85 (-12.9%)
|
0.74
0.74 – 0.74
-12.9% YoY
|
0.85
0.85 – 0.85
+14.9% YoY
|
0.97
0.97 – 0.97
+14.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-28 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-25 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-22 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-21 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-20 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-19 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-18 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-15 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-06 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 367.9K | 0.06% |
| 2 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 224.3K | 0.39% |
| 3 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 40.9K | 0.46% |
| 4 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 96.5K | 0.29% |
| 5 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 12.2K | 0.48% |
| 6 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 27.6K | 0.26% |
| 7 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 104.7K | 0.28% |
| 8 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 1.36M | 0.06% |
| 9 | Vanguard Total International Stock ETF VXUS | 0.00% | 1.43M | 0.05% |
| 10 | Vanguard ESG International Stock ETF VSGX | 0.00% | 8.8K | 0.10% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chuanke Lin | Deputy GM & Director | — | male |
| Jun Yang | Chief Financial Officer, Finance Manager & Accounting Supervisor | — | male |
| Minjuan Wang | Deputy GM & Director | — | female |
| Qingying Wang | Board Secretary | — | male |
| Shao Shengfu | Deputy General Manager | — | male |
| Shen Gaoqing | GM & Director | — | male |
| Wang Hongliang | Deputy GM & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 600273.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
